Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

End-of-day quote. End-of-day quote  - 09/28
2850 INR   +1.03%
09/23 GLAXOSMITHKLINE : Glaxo Files US, European Submissions For Benlysta ..
09/21 GLAXOSMITHKLINE : GSK break-up unlikey after insider Emma Walmsley a..
09/21 Emma named as new Glaxo
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
09/22/2016 09/23/2016 09/26/2016 09/27/2016 09/28/2016 Date
2793(c) 2802(c) 2799.8(c) 2821(c) 2850 Last
34 401 41 160 56 247 15 395 23 206 Volume
-0.41% +0.32% -0.08% +0.76% +1.03% Change
More quotes
Financials ( INR)
Sales 2017 30 891 M
EBIT 2017 5 585 M
Net income 2017 4 460 M
Finance 2017 8 029 M
Yield 2017 1,90%
Sales 2018 35 213 M
EBIT 2018 7 220 M
Net income 2018 5 537 M
Finance 2018 4 453 M
Yield 2018 2,02%
P/E ratio 2017 51,81
P/E ratio 2018 41,84
EV / Sales2017 7,48x
EV / Sales2018 6,66x
Capitalization 239 108 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
10/27Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
09/23 GLAXOSMITHKLINE : Glaxo Files US, European Submissions For Benlysta In Systemic ..
09/21 GLAXOSMITHKLINE PHARMACEUTICALS : GSK break-up unlikey after insider Emma Walmsl..
09/21 Emma named as new Glaxo
09/21 Emma named as new Glaxo chief
09/20 LONDON BRIEFING : GlaxoSmithKline Promotes Emma Walmsley To Be New CEO
09/20 TOP NEWS : Glaxo Promotes Consumer Healthcare Boss Emma Walmsley To CEO
09/15 TOP NEWS : Glaxo Sees Positive Phase III Results For Shingles Vaccine
09/14 GLAXOSMITHKLINE : shingles vaccine shows positive results in adults 70 and older
09/12 GLAXOSMITHKLINE : Glaxo Seeking EU Marketing Approval For Rheumatoid Arthritis T..
09/08 GLAXOSMITHKLINE PLC (NYSE : GSK) Is Betting On A New Treatment Regime For HIV
More news
Sector news : Pharmaceuticals - NEC
12:11pDJGLAXOSMITHKLINE : to Sell Remaining 6.2% Stake in Aspen Pharmacare
08:13a Monsanto ally Novozymes sees opportunity, risk in Bayer merger
09/27DJPFIZER : Scraps Plan to Break Up Company -- WSJ
09/26DJMYLAN : EpiPen Pretax Profits 60% Higher Than Number Told to Congress -- 3rd Upd..
09/26 MYLAN : faces scrutiny over EpiPen profit data shown to Congress
More sector news : Pharmaceuticals - NEC
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE P...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 13
Average target price 2 721  INR
Spread / Average Target -3,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Deepak Shantilal Parekh Non-Executive Chairman
Andrew Aristidou Chief Financial Officer & Executive Director
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
D. Sundaram Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMA..-15.16%3 565
JOHNSON & JOHNSON16.06%322 232
ROCHE HOLDING LTD.-12.41%215 081
NOVARTIS AG-10.14%211 231
PFIZER INC.4.80%204 049
MERCK & CO., INC.18.46%171 858
More Results